Oral lichen planus (OLP) is a chronic immune-mediated mucosal disease with a prolonged, recurrent course. Although conventional models explain basal keratinocyte injury through T-cell-mediated cytotoxicity, they do not fully account for site-restricted chronicity or recurrence after clinical improvement. Single-cell, immune repertoire, and spatial studies have identified tissue-associated CD8+ T-cell states, fibroblast subsets, and organized lymphoid structures within the affected mucosa. OLP-specific studies link tissue-resident memory T (TRM)-like CD8+ cells near the epithelial basement membrane to erosive disease and recurrent erosions. Tertiary lymphoid structures (TLSs) are frequently observed in OLP. CCL19+ fibroblast-associated TLS organization has been linked to atrophic erosive disease and greater clinical activity, and TLS-related humoral activation has been associated with erosive and recurrent phenotypes. SFRP2+WNT5A+ fibroblasts may further amplify T-cell–epithelial inflammation. In contrast, a recent multiomics study of cutaneous and mucosal lichen planus found no prominent canonical TRM signature and identified CXCL13+ cytotoxic CD8+ T-cells associated with an inferred classical type 2 dendritic cell subset A– interleukin-15 interaction and spatially linked to epithelial responses. This review compares these findings through two nonexclusive hypotheses: cellular persistence, in which pathogenic lymphocytes remain within the affected mucosa, and niche persistence, in which local stromal, myeloid, and lymphoid components retain the capacity to reactivate or regenerate cytotoxic T-cell states. Because current evidence is predominantly cross-sectional, persistent clonotypes, direct TRM–TLS interactions, and causal roles in recurrence remain undetermined. Longitudinal same-site sampling with clonotype tracking and spatial profiling is required to identify which tissue features remain after clinical improvement and which features predict recurrence.